Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors

Kazutoshi Takahashi, Shinya Yamanaka · Cell · 2006 · 26.2K citations · Full text

Tissue Engineering, Regenerative Medicine, Defined Factors +14

Generation of germline-competent induced pluripotent stem cells

Keisuke Okita, Tomoko Ichisaka, Shinya Yamanaka · Nature · 2007 · 4.2K citations

Induced Pluripotent Stem Cell, Developmental Biology, Medicine +6

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore, David Goldstein, John Hamm et al. · Journal of Clinical Oncology · 2007 · 3.8K citations

Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer

Patrick Hermann, Stephan Huber, Tanja Herrler et al. · Cell stem cell · 2007 · 2.9K citations · Full text

Metastatic Activity, Pancreatic Cancer, Medicine +12

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

Richard A. Moffitt, Raoud Marayati, Elizabeth L. Flate et al. · Nature Genetics · 2015 · 2.1K citations · Full text

Virtual Microdissection Identifies, Tumor Biology, Pancreatic Cancer +10